{"id":77097,"date":"2021-04-07T11:44:19","date_gmt":"2021-04-07T10:44:19","guid":{"rendered":"https:\/\/www.commercialriskonline.com\/?p=77097"},"modified":"2021-04-15T10:21:21","modified_gmt":"2021-04-15T09:21:21","slug":"life-sciences-face-complex-and-changed-risk-landscape-says-wtw","status":"publish","type":"post","link":"https:\/\/www.commercialriskonline.com\/life-sciences-face-complex-and-changed-risk-landscape-says-wtw\/","title":{"rendered":"Life sciences face \u2018complex\u2019 and \u2018changed\u2019 risk landscape, says WTW"},"content":{"rendered":"
\n
\n

Life science firms must address new risks driven by changes to their business during the response to Covid-19, with insurers \u201cplaying catchup\u201d, according to a sector report from Willis Towers Watson (WTW).<\/p>\n

WTW says the lif...<\/p>\n <\/div>\n

\n
\n

Want to read this article?<\/h2>\n

Register<\/a> for ultimate access to this article and ALL our premium content<\/p>\n

ULTIMATE ACCESS<\/strong> PROVIDES YOU WITH<\/strong><\/p>\n